Literature DB >> 24033697

Diagnostic utility of D-dimer concentrations in dogs with pulmonary embolism.

S E Epstein1, K Hopper, M S Mellema, L R Johnson.   

Abstract

BACKGROUND: Pulmonary embolism (PE) is a complication of systemic disease in dogs. Antemortem diagnosis is challenging because of the lack of a confirmatory test.
OBJECTIVES: To retrospectively determine the diagnostic utility of D-dimer concentrations in dogs with necropsy-confirmed PE. ANIMALS: Ten dogs with PE confirmed at necropsy that had D-dimer concentrations measured and 10 control dogs with D-dimer concentrations available that lacked PE on necropsy.
METHODS: The computerized medical record database was searched for dogs with necropsy-confirmed PE that had D-dimer concentrations measured at that visit. An age-, sex-, and breed-matched control group was identified. Signalment, location of PE, and coagulation profiles were collected. Sensitivity, specificity, negative predictive value (NPV), and positive predictive value (PPV) were calculated using a D-dimer concentration of 250 ng/mL.
RESULTS: Coagulation profiles were not different between dogs with and without PE. Using 250 ng/mL as a cut-off D-dimer concentration, the sensitivity and specificity were 80 and 30%, respectively, for the diagnosis of PE. The NPV and PPV were 60 and 53.0%, respectively. D-dimer concentration <103 ng/mL had 100% sensitivity for ruling out PE and no value was 100% specific. CONCLUSIONS AND CLINICAL IMPORTANCE: D-dimer concentrations <250 ng/mL have a high sensitivity for the absence of PE, but PE still can occur in dogs with a normal D-dimer concentration. Increased D-dimer concentrations are not specific for PE.
Copyright © 2013 by the American College of Veterinary Internal Medicine.

Entities:  

Keywords:  Biomarker; Coagulation; Respiratory distress; Thromboembolism

Mesh:

Substances:

Year:  2013        PMID: 24033697     DOI: 10.1111/jvim.12177

Source DB:  PubMed          Journal:  J Vet Intern Med        ISSN: 0891-6640            Impact factor:   3.333


  8 in total

1.  Investigation of two different human d-dimer assays in the horse.

Authors:  Marie Louise Honoré; Tina H Pihl; Tanne M Busk-Anderson; Laura L Flintrup; Lise N Nielsen
Journal:  BMC Vet Res       Date:  2022-06-15       Impact factor: 2.792

2.  Interstitial pneumonia and pulmonary hypertension associated with suspected ehrlichiosis in a dog.

Authors:  Marjolein Lisette den Toom; Tetyda Paulina Dobak; Els Marion Broens; Chiara Valtolina
Journal:  Acta Vet Scand       Date:  2016-07-07       Impact factor: 1.695

Review 3.  Cardiopulmonary and inflammatory biomarkers in heartworm disease.

Authors:  Elena Carretón; Rodrigo Morchón; José Alberto Montoya-Alonso
Journal:  Parasit Vectors       Date:  2017-11-09       Impact factor: 3.876

4.  Cell-Free DNA and DNase Activity in Dogs with Immune-Mediated Hemolytic Anemia.

Authors:  U Jeffery; L Ruterbories; R Hanel; D N LeVine
Journal:  J Vet Intern Med       Date:  2017-08-20       Impact factor: 3.333

5.  Retrospective evaluation of pimobendan and sildenafil therapy for severe pulmonary hypertension due to lung disease and hypoxia in 28 dogs (2007-2013).

Authors:  Lisa A Murphy; Nicholas Russell; Domenico Bianco; Reid K Nakamura
Journal:  Vet Med Sci       Date:  2017-03-08

6.  Clinical features and outcome in 25 dogs with respiratory-associated pulmonary hypertension treated with sildenafil.

Authors:  Lynelle R Johnson; Joshua A Stern
Journal:  J Vet Intern Med       Date:  2019-12-09       Impact factor: 3.333

7.  Urinary 11-dehydrothromboxane B2 concentrations in 20 dogs with primary immune-mediated hemolytic anemia.

Authors:  Elizabeth A Conway; Neil P Evans; Alison E Ridyard
Journal:  J Vet Intern Med       Date:  2021-12-03       Impact factor: 3.333

8.  Outcome and prognostic factors in infective endocarditis in dogs: 113 cases (2005-2020).

Authors:  Krystle L Reagan; Lance C Visser; Steven E Epstein; Joshua A Stern; Lynelle R Johnson
Journal:  J Vet Intern Med       Date:  2022-03-09       Impact factor: 3.333

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.